tcsc2505 Bupivacaine (hydrochloride)

Order Now

AVAILABLE SIZES

$103.00 ORDERING INFORMATION International
TAICLONE BIOTECH CORP.
order@taiclone.com
+886-2-2735-9682
+886-2-2735-9807

Data sheet

Download PDF Datasheet

Technical Inquries

Submit Review

Product Description

Bupivacaine Hydrochloride is a local anaesthetic drug belonging to the amino amide group.

Target: Others

Bupivacaine hydrochloride is an effective local anesthetic agent. It has a rapid onset time, a high frequency of surgical anesthesia, a long duration, and a low incidence of side effects [1]. Median doses of bupivacaine (in milligrams per kilogram) producing asystole in protocol 1 were for 17.7 for saline, 27.6 for 10% Intralipid, 49.7 for 20% Intralipid, and 82.0 for 30% Intralipid (P < 0.001 for differences between all groups). Differences in mean +/- SE concentrations of bupivacaine in plasma (in micrograms per milliliter) were significant (P < 0.05) for the difference between saline (93.3 +/- 7.6) and 30% Intralipid (212 +/- 45). In protocol 2, lipid infusion increased the dose of bupivacaine required to cause death in 50% of animals by 48%, from 12.5 to 18.5 mg/kg. The mean lipid:aqueous ratio of concentrations of bupivacaine in a plasma-Intralipid mixture was 11.9 +/- 1.77 (n = 3) [2].

Information

CAS No18010-40-7
FormulaC18H29ClN2O
Clinical InformationLaunched
PathwayMAPK/ERK Pathway
TargetRibosomal S6 Kinase (RSK)

Specifications

Purity / Grade>98%
Solubility10 mM in DMSO

Misc Information

Observed Molecular Weight324.89
Get valuable resources and offers directly to your email.